As SARS-CoV-2 continues to spread and cause diseases, emerging variants of the
virus are being identified around the globe.
The persisting challenges of SARS-CoV-2 to the international public health system
have elicited concerns among scientists, drug and vaccine developers and the
general population. Whether current therapeutic antibodies and vaccines against
the circulating and emerging variants can provide enough protection becomes a
primary issue.
ACROBiosystems has been tracking the most up-to-date genomic data of the virus
and going full steam ahead on SARS-CoV-2 variants-related product development.
Now we present a complete solution to support your research and development
on the variants: a collection of recombinant antigens, antibodies, ELISA kits
and magnetic beads is now available now at ACROBiosystems.
Find out more information here
DBA-ITALIA Srl
Via Umbria 10
20054 Segrate (Milano)
Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535